Recontacting in medical genetics: the implications of a broadening knowledge base.
Autor: | Doheny S; Cardiff University Institute of Cancer and Genetics, Cardiff, SGM, UK. dohenys1@cardiff.ac.uk. |
---|---|
Jazyk: | angličtina |
Zdroj: | Human genetics [Hum Genet] 2022 May; Vol. 141 (5), pp. 1045-1051. Date of Electronic Publication: 2021 Aug 30. |
DOI: | 10.1007/s00439-021-02353-5 |
Abstrakt: | The practice of recontacting patients has a long history in medicine but emerged as an issue in genetics as the rapid expansion of knowledge and of testing capacity raised questions about whether, when and how to recontact patients. Until recently, the debate on recontacting has focussed on theoretical concerns of experts. The publication of empirical research into the views of patients, clinicians, laboratories and services in a number of countries has changed this. These studies have filled out, and altered our view of, this issue. Whereas debates on the duty to recontact have explored all aspects of recontact practice, recent contributions have been developing a more nuanced view of recontacting. The result is a narrowing of the scope of the duty, so that a norm on recontacting focuses on the practice of reaching out to discharged patients. This brings into focus the importance of the consent conversation, the resource implications of this duty, and the role of the patient in recontacting. (© 2021. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |